TOMZ

Business Context and Reporting Period

Company: TOMI Environmental Solutions, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2011
Business Overview: TOMI provides surface and air decontamination and infectious disease control solutions, including Hydrogen Peroxide misters and UVGI products. The company operates in North America and has established subsidiaries in Singapore (55% owned) and China (55% owned, established April 2011).
Going Concern Status: The filing explicitly states substantial doubt about the company's ability to continue as a going concern due to limited revenues, negative working capital, and negative operating cash flows.

Key Financial Metrics

Note: Total Debt includes $8,292 in notes payable and $53,868 in loans payable (primarily from the CEO).

Material Changes vs. Prior Period

• Revenue Decline: Net revenue decreased by approximately 45% ($123,071) compared to Q1 2010. Management attributes this to a shift in business model from large equipment sales/licensing to a broader customer base with smaller transaction sizes.
• Expense Structure:
  • Professional Fees: Increased from $40,016 to $66,180 due to higher legal and accounting costs.
  • General & Administrative (G&A): Increased from $254,078 to $362,399. This includes a significant non-cash charge of $207,177 for share-based compensation (issuing stock to the CEO for accrued wages).
  • Management Fees: Decreased to $0 from $284,651 as deferred compensation related to a prior management agreement was fully amortized by the end of 2010.
• Other Income: Decreased significantly due to the absence of a $67,366 gain on the sale of equipment recorded in Q1 2010.
• Liquidity: Cash on hand increased from $863 (Q1 2010) to $34,639 (Q1 2011), primarily driven by financing activities (stock sales and loans) rather than operations.

Outlook, Risks, and Unusual Items

• Liquidity Risk: The company has an "immediate and urgent need for additional capital." Operations are funded by licensing, debt, and equity sales. Failure to raise funds could force a curtailment of operations.
• Unusual Non-Cash Transactions:
  • The CEO forgave $700,269 in accrued compensation, recorded as a capital contribution.
  • The company issued 14,076,923 shares to the CEO to settle $366,000 in accrued compensation, with the excess fair value recorded as expense.
• Strategic Developments:
  • Entered a joint venture with Zera Investments in Singapore for marketing and capital raising.
  • Established a Chinese subsidiary (TOMI-China) in April 2011.
  • Secured an independent sales agent in the U.S. (Accu-Med) in May 2011.
• Legal Proceedings: The company is subject to a legal proceeding but management does not expect a material adverse effect.

Investor Verification Checklist

• Capital Adequacy: Verify the company's ability to secure the "immediate and urgent" capital needed to avoid ceasing operations, given the negative working capital of $(252,190).
• Revenue Sustainability: Assess whether the shift from large equipment sales to smaller transactions will result in sustainable revenue growth or continued volatility.
• Related Party Transactions: Review the terms of the $53,844 loan from the CEO and the recent issuance of over 14 million shares to the CEO for accrued wages to understand potential dilution and governance risks.
• Going Concern Status: Confirm if the "substantial doubt" regarding the company's ability to continue as a going concern has been resolved in subsequent filings.
• International Expansion: Evaluate the progress and financial impact of the new Singapore and China subsidiaries and the joint venture with Zera Investments.